➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Boehringer Ingelheim
Colorcon
Merck
Dow

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Diphencyprone


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Diphencyprone?

Diphencyprone is an investigational drug.

There have been 4 clinical trials for Diphencyprone. The most recent clinical trial was a Phase 1 trial, which was initiated on March 14th 2017.

The most common disease conditions in clinical trials are Hypersensitivity, Delayed, Hypersensitivity, and Neoplasm Metastasis. The leading clinical trial sponsors are Innovaderm Research Inc., Rockefeller University, and Brickell Biotech, Inc.

There are eighty-six US patents protecting this investigational drug and six hundred and eleven international patents.

Recent Clinical Trials for Diphencyprone
TitleSponsorPhase
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy VolunteersInnovaderm Research Inc.N/A
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact DermatitisBrickell Biotech, Inc.Phase 1
Effect of RANKL Inhibition on UV-induced ImmunosuppressionInnovaderm Research Inc.Phase 1

See all Diphencyprone clinical trials

Clinical Trial Summary for Diphencyprone

Top disease conditions for Diphencyprone
Top clinical trial sponsors for Diphencyprone

See all Diphencyprone clinical trials

US Patents for Diphencyprone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Diphencyprone   Start Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Start Trial
Diphencyprone   Start Trial Topical compositions and methods for making and using same SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM)   Start Trial
Diphencyprone   Start Trial Topical compositions and methods for making and using same SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM)   Start Trial
Diphencyprone   Start Trial Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection Squarex, LLC (Pine Springs, MN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Diphencyprone

Drugname Country Document Number Estimated Expiration Related US Patent
Diphencyprone Australia 2017261372 2036-05-05   Start Trial
Diphencyprone Canada 3023278 2036-05-05   Start Trial
Diphencyprone China 107847398 2036-05-05   Start Trial
Diphencyprone European Patent Office 3452003 2036-05-05   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.